Aspirin Boosts Polypill Primary Prevention, Claims Meta-Analysis Aspirin Boosts Polypill Primary Prevention, Claims Meta-Analysis

Polypills or other fixed-dose CV drug combos -- with or without aspirin, but especially with -- substantially cut risk in a meta-analysis of primary-prevention trials with a controversial message.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news
More News: Aspirin | Cardiology | Heart